机构:[1]Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室肿瘤内科昆明医科大学附属第一医院[2]HaploX Biotechnology, Shenzhen, China[3]Department of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming, China医技科室病理科昆明医科大学附属第一医院
Primary sarcomatoid carcinoma (SCA) is a type of rare tumor consisting of both malignant epithelial and mesenchymal components. Only 32 cases of SCA of the small bowel have been reported in the literature to date. Due to its rarity and complexity, this cancer has not been genetically studied and its diagnosis and treatment remain difficult. Here we report a 54-year-old male underwent emergency surgical resection in the small intestine due to severe obstruction and was diagnosed with multiple SCA based on postoperative pathological examination. Over 100 polypoid tumors scattered along his whole jejunum and proximal ileum. Chemotherapy (IFO+Epirubicin) was performed after surgery while the patient died two months after the surgery due to severe malnutrition. Whole-exome sequencing was performed for the tumor tissue with normal tissue as the control. Important cancer-related gene mutations, including KRAS (c.37G>T, p.G13C), TP53 (c.871A>T, p.K291*), EGFR (c.1351C>T, p.R451C), and CDKN2A (c.104_138del, p.G35fs), were found among 286 nonsynonymous somatic mutations (SNV and Indel). Copy-number amplified genes mainly gathered in chromosome 6, 7, 16 and 20. Mutation clustering analysis showed that main genetic abnormalities included DNA methylation, DNA alkylation, cellular homeostasis, and shared similarities with melanoma, glioma, prostate cancer, bladder cancer, non-small cell lung cancer, and pancreatic cancer. In summary, the genomic features of the small intestine SCA were explored at whole-exome level for the first time, and over 200 somatic mutations were identified in the tumor tissue. Key tumor driver gene mutations were revealed, as well as several aberrant functional pathways. These results contribute to further understanding of the pathogenesis and molecular mechanism of this rare tumor.
基金:
This study was supported by the grants from the
Yunnan Provincial Health Commission Medical Reserve
Talents Training Program (grant number H-201633), Project of Yunnan Science and Technology Department
(grant number 2019FB114), the Special Funds for
Strategic Emerging Industry Development of Shenzhen
(grant number 20170922151538732), and the Science
and Technology Project of Shenzhen (grant number
JSGG20180703164202084).
第一作者机构:[1]Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China
共同第一作者:
通讯作者:
通讯机构:[*1]Department of Oncology, First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Kunming 560032, Yunnan Province, China.[*2]HaploX Biotechnology, 8th floor, Auto Electric Power Building, Songpingshan Road, Nanshan District, Shenzhen 518057, Guangdong Province, China.
推荐引用方式(GB/T 7714):
Zhu Zhu,Xinyi Liu,Wenliang Li,et al.A rare multiple primary sarcomatoid carcinoma (SCA) of small intestine harboring driver gene mutations: a case report and a literature review[J].TRANSLATIONAL CANCER RESEARCH.2021,10(2):1150-+.doi:10.21037/tcr-20-2829.
APA:
Zhu Zhu,Xinyi Liu,Wenliang Li,Zhengqi Wen,Xiang Ji...&Jian Huang.(2021).A rare multiple primary sarcomatoid carcinoma (SCA) of small intestine harboring driver gene mutations: a case report and a literature review.TRANSLATIONAL CANCER RESEARCH,10,(2)
MLA:
Zhu Zhu,et al."A rare multiple primary sarcomatoid carcinoma (SCA) of small intestine harboring driver gene mutations: a case report and a literature review".TRANSLATIONAL CANCER RESEARCH 10..2(2021):1150-+